ATABAY Group of companies: A leader in the production of Paracetamol (Acetaminophen) powder and direct compression grades in its FDA USA-approved and EU, back integrated and dedicated cGMP plant. Back integration covers production of p-aminophenol which is acetylated to Paracetamol and re-crystallized with water as solvent.

Products conform to the current BP, USP, PH EUR pharmacopeias and has COS from EDQM.

Atabay provdies an injectable form of Paracetamol and produces a wide-range of pharmaceutical drugs such as beta-lactam antibiotics, analgesics, antirheumatics, antituberculosis products in tablets, suppositories, syrup, suspension, cream/ointment and sachet dosage forms. Atabay is currently developing generic antiviral drugs with in-house synthesized APIs.

Sales Markets

Middle East Region (e.g. UAE); North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Primary business activity

Manufacturer/Innovator

Meet us at

CPhI Worldwide 2021

Fiera Milano, Milan, Italy

9-11 November 2021

Book a meeting
View Our Exhibitor Profile

Contact information

Address

Telephone

Website

View All Contact Info